Trials / Completed
CompletedNCT01967160
Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid
A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,560 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
A non-interventional study to assess incident rates of Osteonecrosis of the Jaw and Infections leading to hospitalization in Cancer patients treated with XGEVA™ in Sweden, Denmark and Norway.
Conditions
Timeline
- Start date
- 2012-01-02
- Primary completion
- 2019-08-05
- Completion
- 2019-08-05
- First posted
- 2013-10-22
- Last updated
- 2023-06-22
Source: ClinicalTrials.gov record NCT01967160. Inclusion in this directory is not an endorsement.